How Is Endoscopic Submucosal Dissection for Gastrointestinal Lesions Being Implemented? Results from an International Survey.

Endoscopic submucosal dissection Gastrointestinal superficial lesions Survey

Journal

GE Portuguese journal of gastroenterology
ISSN: 2341-4545
Titre abrégé: GE Port J Gastroenterol
Pays: Switzerland
ID NLM: 101685861

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 28 03 2019
accepted: 11 05 2019
entrez: 24 1 2020
pubmed: 24 1 2020
medline: 24 1 2020
Statut: ppublish

Résumé

Superficial gastrointestinal (GI) neoplasms can be treated with endoscopic mucosal resection (EMR) and/or endoscopic submucosal dissection (ESD). These techniques are widely used in Eastern countries; however, its use in the West is limited. The aim of this study was to evaluate the current implementation of ESD in Western countries. Western endoscopists ( A total of 58 endoscopists (21%) completed the survey. Thirty performed ESD in the esophagus (52%), 45 in the stomach (78%), 36 in the co-lorectum (62%), and 6 in the duodenum (10%). The median total number of lesions ever treated per endoscopist was 190, with a median number per endoscopist in 2016 of 41 (7 [IQR 1-21], 6 [IQR 4-16], and 28 [5-63] in the esophagus, in the stomach, and in the colon and rectum, respectively). En bloc resection rates were 97% in the esophagus, 95% in the stomach, and 84% in the colorectum. Complete resection (R0) was achieved in 88, 91, and 81%, respectively. Curative rates were 69, 70, and 67%, respectively. Major complications (perforation or delayed bleeding) occurred more often in colorectal ESD (12 vs. 6% in the esophagus and 7% in the stomach). In the upper GI tract, the majority of resected lesions were intramucosal adenocarcinoma (59% in the esophagus; 47% in the stomach), while in the colorectum the majority were adenomas (59%). ESD seems to be performed by a large number of centers and endoscopists. Our results suggest that ESD is being successfully implemented in Western countries, achieving a good rate of efficacy and safety according to European guidelines. As lesões superficiais gastrointestinais podem ser tratadas por musectomia (EMR) e/ou disseção endoscópica da submucosa (ESD). Estas técnicas são usadas frequentemente nos países asiáticos, mas a experiência é mais limitada nos países ocidentais. O objetivo deste estudo foi avaliar a implementação atual da ESD nos países ocidentais. Gastroenterologistas ocidentais ( Um total de 58 gastroenterologistas (21%) completou o inquérito. Trinta realizaram ESD esofágica (52%); 45 gástrica (78%); 36 coloretal (62%); e 6 duodenal (10%). A mediana do número total de lesões ressecadas por endoscopista foi 190, sendo que, em 2016, a mediana de lesões tratadas por cada gastroenterologista foi 41 (7 [IQR 1–21] no esófago, 6 [IQR 4–16] no estómago e 28 [5–63] no côlon e reto). A taxa de ressecção em bloco foi de 97% nas lesões esofágicas; 95% nas lesões gástricas e 84% nas lesões coloretais, com uma proporção de casos RO de 88, 91 e 81%, respetivamente. A taxa de casos curados foi de 69, 70 e 67%, respetivamente. A taxa de complicações graves (perfuração e hemorragia tardia) foi maior na ESD coloretal (12% dos casos vs. 6% no esófago e 7% no estômago). A maioria das lesões esofagogástricas eram adenocarcinomas intramucosos (59% no esófago; 47% no estômago), enquanto as lesões coloretais eram maioritariamente adenomas (59%). Este estudo mostra uma disseminação da ESD na europa por um maior número de centros e gas-trenterologistas. Os nossos resultados sugerem uma utilização e eficácia global de acordo corn as recomendações europeias.

Sections du résumé

BACKGROUND AND STUDY AIM OBJECTIVE
Superficial gastrointestinal (GI) neoplasms can be treated with endoscopic mucosal resection (EMR) and/or endoscopic submucosal dissection (ESD). These techniques are widely used in Eastern countries; however, its use in the West is limited. The aim of this study was to evaluate the current implementation of ESD in Western countries.
METHODS METHODS
Western endoscopists (
RESULTS RESULTS
A total of 58 endoscopists (21%) completed the survey. Thirty performed ESD in the esophagus (52%), 45 in the stomach (78%), 36 in the co-lorectum (62%), and 6 in the duodenum (10%). The median total number of lesions ever treated per endoscopist was 190, with a median number per endoscopist in 2016 of 41 (7 [IQR 1-21], 6 [IQR 4-16], and 28 [5-63] in the esophagus, in the stomach, and in the colon and rectum, respectively). En bloc resection rates were 97% in the esophagus, 95% in the stomach, and 84% in the colorectum. Complete resection (R0) was achieved in 88, 91, and 81%, respectively. Curative rates were 69, 70, and 67%, respectively. Major complications (perforation or delayed bleeding) occurred more often in colorectal ESD (12 vs. 6% in the esophagus and 7% in the stomach). In the upper GI tract, the majority of resected lesions were intramucosal adenocarcinoma (59% in the esophagus; 47% in the stomach), while in the colorectum the majority were adenomas (59%).
CONCLUSION CONCLUSIONS
ESD seems to be performed by a large number of centers and endoscopists. Our results suggest that ESD is being successfully implemented in Western countries, achieving a good rate of efficacy and safety according to European guidelines.
INTRODUÇÃO E OBJETIVOS UNASSIGNED
As lesões superficiais gastrointestinais podem ser tratadas por musectomia (EMR) e/ou disseção endoscópica da submucosa (ESD). Estas técnicas são usadas frequentemente nos países asiáticos, mas a experiência é mais limitada nos países ocidentais. O objetivo deste estudo foi avaliar a implementação atual da ESD nos países ocidentais.
MÉTODOS UNASSIGNED
Gastroenterologistas ocidentais (
RESULTADOS RESULTS
Um total de 58 gastroenterologistas (21%) completou o inquérito. Trinta realizaram ESD esofágica (52%); 45 gástrica (78%); 36 coloretal (62%); e 6 duodenal (10%). A mediana do número total de lesões ressecadas por endoscopista foi 190, sendo que, em 2016, a mediana de lesões tratadas por cada gastroenterologista foi 41 (7 [IQR 1–21] no esófago, 6 [IQR 4–16] no estómago e 28 [5–63] no côlon e reto). A taxa de ressecção em bloco foi de 97% nas lesões esofágicas; 95% nas lesões gástricas e 84% nas lesões coloretais, com uma proporção de casos RO de 88, 91 e 81%, respetivamente. A taxa de casos curados foi de 69, 70 e 67%, respetivamente. A taxa de complicações graves (perfuração e hemorragia tardia) foi maior na ESD coloretal (12% dos casos vs. 6% no esófago e 7% no estômago). A maioria das lesões esofagogástricas eram adenocarcinomas intramucosos (59% no esófago; 47% no estômago), enquanto as lesões coloretais eram maioritariamente adenomas (59%).
CONCLUSÕES UNASSIGNED
Este estudo mostra uma disseminação da ESD na europa por um maior número de centros e gas-trenterologistas. Os nossos resultados sugerem uma utilização e eficácia global de acordo corn as recomendações europeias.

Autres résumés

Type: Publisher (por)
As lesões superficiais gastrointestinais podem ser tratadas por musectomia (EMR) e/ou disseção endoscópica da submucosa (ESD). Estas técnicas são usadas frequentemente nos países asiáticos, mas a experiência é mais limitada nos países ocidentais. O objetivo deste estudo foi avaliar a implementação atual da ESD nos países ocidentais.

Identifiants

pubmed: 31970235
doi: 10.1159/000501404
pii: pjg-0027-0001
pmc: PMC6959092
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-17

Informations de copyright

Copyright © 2019 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this paper.

Références

J Surg Res. 2016 May 1;202(1):204-15
pubmed: 27083968
Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43
pubmed: 14652541
Endoscopy. 2019 Jan;51(1):30-39
pubmed: 29969807
Gastrointest Endosc. 2016 Oct;84(4):572-86
pubmed: 27345132
Eur J Gastroenterol Hepatol. 2014 Jun;26(6):607-15
pubmed: 24743502
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Endoscopy. 2017 Sep;49(9):855-865
pubmed: 28564714
Endoscopy. 2010 Oct;42(10):814-9
pubmed: 20886399
Dig Dis Sci. 2012 Feb;57(2):435-9
pubmed: 21901257
Gastrointest Endosc. 2012 Oct;76(4):763-70
pubmed: 22884100
Dig Dis Sci. 2015 Feb;60(2):531-6
pubmed: 25092035
Endoscopy. 2017 Mar;49(3):214-216
pubmed: 28249317
Endoscopy. 2015 Sep;47(9):829-54
pubmed: 26317585
United European Gastroenterol J. 2017 Feb;5(1):45-53
pubmed: 28405321
GE Port J Gastroenterol. 2017 Jan;24(1):31-39
pubmed: 28868336
Gut. 2017 May;66(5):783-793
pubmed: 26801885
Endosc Int Open. 2017 Jul;5(7):E595-E602
pubmed: 28670616
Endosc Int Open. 2016 Oct;4(10):E1030-E1044
pubmed: 27747275
Surg Endosc. 2009 Jul;23(7):1581-6
pubmed: 19263148
Endoscopy. 2017 May;49(5):511
pubmed: 28449143
Endoscopy. 2014 Nov;46(11):933-40
pubmed: 25019970
Dig Endosc. 2013 Mar;25 Suppl 1:55-63
pubmed: 23362925
Clin Endosc. 2016 Sep;49(5):454-456
pubmed: 27561263
Gastrointest Endosc. 2017 Mar;85(3):546-553
pubmed: 27475492
Gastrointest Endosc. 2018 Mar;87(3):714-722
pubmed: 28623057
Crit Rev Oncol Hematol. 2016 Aug;104:138-55
pubmed: 27370173
Cancer Commun (Lond). 2018 Mar 21;38(1):3
pubmed: 29764504
Endoscopy. 2010 Oct;42(10):853-8
pubmed: 20623442
Gut. 2018 Aug;67(8):1464-1474
pubmed: 29208675
United European Gastroenterol J. 2016 Feb;4(1):18-29
pubmed: 26966519
World J Gastrointest Endosc. 2016 Aug 10;8(15):517-32
pubmed: 27606044
BMC Gastroenterol. 2016 May 26;16(1):56
pubmed: 27229709
World J Gastrointest Endosc. 2016 Feb 10;8(3):173-9
pubmed: 26862367

Auteurs

Miguel Araújo-Martins (M)

Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

Pedro Pimentel-Nunes (P)

Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

Diogo Libânio (D)

Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.

Marta Borges-Canha (M)

Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

Mário Dinis-Ribeiro (M)

Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.

Classifications MeSH